Emerging therapeutic interventions mitigating ferroptosis in DN have focused on three core regulatory axes: (1) GPX4 stabilization, (2) Nrf2-mediated antioxidant defense potentiation, and (3) iron homeostasis restoration. Here, GPX4 is linked to liver dysplastic nodule.